Old Web
English
Sign In
Acemap
>
authorDetail
>
Kendall A. Heetderks
Kendall A. Heetderks
Duke University
Cancer research
Estrogen receptor
Fulvestrant
Medicine
Breast cancer
3
Papers
32
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Inhibition of estrogen signaling in myeloid cells increases tumor immunity in melanoma
2021
Journal of Clinical Investigation
Binita Chakraborty
Jovita Byemerwa
Jonathan Shepherd
Corinne N Haines
Robert Baldi
Weida Gong
Wen Liu
Debarati Mukherjee
Sandeep Artham
Felicia Lim
Yeeun Bae
Olivia Brueckner
Kendall A. Heetderks
Suzanne E. Wardell
Brent A. Hanks
Charles M. Perou
Ching-Yi Chang
Donald P. McDonnell
Show All
Source
Cite
Save
Citations (0)
G1T48, an oral selective estrogen receptor degrader, and the CDK4/6 inhibitor lerociclib inhibit tumor growth in animal models of endocrine-resistant breast cancer
2020
Breast Cancer Research and Treatment
Kaitlyn J. Andreano
Suzanne E. Wardell
Jennifer G. Baker
Taylor K. Desautels
Robert Baldi
Christina A. Chao
Kendall A. Heetderks
Yeeun Bae
Rui Xiong
Debra A. Tonetti
Lauren M. Gutgesell
Jiong Zhao
Jessica A. Sorrentino
Delita A. Thompson
John E. Bisi
Jay C. Strum
Gregory R. J. Thatcher
John D. Norris
Show All
Source
Cite
Save
Citations (14)
1